The aim of this study is to investigate the prevalence and the commonest degree of thrombocytopenia among pregnant women in Tripoli region, Libya. This is cross section study included pregnant women who were admitted to obstetrical ward department of obstetrics and gynecology in Al-gala Hospital, Tripoli, Libya. This study was carried out over a period of 5 month from February 2009 to June 2009 on 3520 pregnant women. 5 ml of venous blood specimens were take from each pregnant woman in K3 EDTA (tubes for the haematological examinations. The analysis of haematological indices was done using automated hematological analyzer. The results showed that 17% of pregnant women were thrombocytopenic. Thrombocytopenia increased with increase of age pregnant women. 81% of patients had mild thrombocytopenia and 19% of patients had moderate thrombocytopenia were found in this study when compared with control group. The incidence of mild thrombocytopenia was 42.5% in age group (30 -39) Followed by 37.8% in age group (20-29). The prevalence of thrombocytopenia increased with increase of the gestational age to reach maximum at the third trimester of gestation. Association of onset of thrombocytopenia disorder with age distribution of patients in age group 20-29 years old were 2.7% during first trimester, 17.8% during second trimester and 79.5% during third trimester. In age group 30 – 39 years old were 3.2% during first trimester, 10.8% during second trimester and 86% during third trimester. In age group 40-49 years old were 46.7% during second trimester and 53.3 during third trimester. 37% of thrombocytopenic pregnant women were anaemic. Association of onset of anaemia disorder with age distribution of patients in age group 20-29 years old were 26.9% during second trimester and 73.1% during third trimester. In age group 30 – 39 years old were 14.3% during second trimester and 85.7% during third trimester. Data shows that 26% of patients had mild anaemia and 8.8% of patients had moderate anaemia and 1.8% severe anaemia cases were found in this study when compared with 62.9% non anaemic. It can be concluded that thrombocytopenia disorders in pregnancy are very common in Tripoli region. Careful surveillance is required for these pregnancies in high-risk units for early detection and treatment of possible complications, in order to try to reduce maternal and neonatal morbidities. Further prospective studies among these high-risk populations with moderate to severe thrombocytopenia should investigate the efficacy of possible surveillance programs.
| Published in | Cardiology and Cardiovascular Research (Volume 1, Issue 1) |
| DOI | 10.11648/j.ccr.20170101.14 |
| Page(s) | 23-28 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2017. Published by Science Publishing Group |
Anaemia in Thrombocytopenic Patients, Pregnant Women, Trimesters of Pregnancy, Thrombocytopenia
| [1] | Chandra S., Tripathi K., Mishra S., Amzarul M., and Vaish A. (2012). Physiological changes in hematological parameters during pregnancy. Indian J. Hematol. Blood Transfus., 28 (3): 144–146. |
| [2] | Akinlaja O. (2016). Hematological changes in pregnancy - the preparation for intrapartum blood loss. Obstet. Gynecol. Int. J., 4 (3): 00109. |
| [3] | Abbassi-Ghanavati M., Greer L. G., and Cunningham F. G. (2006). Pregnancy and laboratory studies: a reference table for clinicians. Obstet. Gynecol., 114 (6): 1326–1331. |
| [4] | Boehlen F., Hohlfeld P., Extermann P., Perneger T. V., and de Moerloose P. (2000). Platelet count at term pregnancy: A reappraisal of the threshold. Obstet. Gynecol., 95 (1): 29–33. |
| [5] | Jensen J. D., Wiedmeier S. E., Henry E., Silver R. M., and Christensen R. D. (2011). Linking maternal platelet counts with neonatal platelet counts and outcomes using the data repositories of a multihospital health care system. Am. J. Perinatol., 28 (8): 597-604. |
| [6] | Stevens G., Finucane M., De-Regil L., Paciorek C., Flaxman S., Branca F. et al. (2013). Nutrition impact model study group (Anaemia). Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: A systematic analysis of population-representative data. Lancet Glob Health., 1: 16-25. |
| [7] | Boehlen, F., Hohlfeld, P., Extermann, P., and de Moerloose, P. (1999). Maternal antiplatelet antibodies in predicting risk of neonatal thrombocytopenia. Obstet. Gynecol., 93 (2): 169-173. |
| [8] | Cook, R. L., Miller, R. C., Katz, V. L., and Cefalo, R. C. (1991). Immune thrombocytopenic purpura in pregnancy: A reappraisal of management. Obstet. Gynecol., 78: 578 –583. |
| [9] | Sainio, S., Kekomaki, R., Riikonen, S., and Teramo, K. (2000). Maternal thrombocytopenia: a population based study. Acta. Obstet. Gynecol. Scand., 79: 744–749. |
| [10] | McCrae KR. (2003). Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis and management. Blood Rev., 17: 7-14. |
| [11] | Webert, K. E., Mittal, R., Sigouin, C., Heddle, N. M., and Kelton, J. G. (2003). A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood, 102 (13): 4306 - 4311. |
| [12] | Kam, P. C., Thompson, S. A., and Liew, A. C. (2004). Review article, thrombocytopenia in the parturient. Anaesth., 59: 255–264. |
| [13] | Kwon, J. Y., Shin, J. C., Lee, J. W., Lee, J. K., Kim, S. P., and Rha, J. G. (2007). Predictors of idiopathic thrombocytopenic purpura in pregnant women presenting with thrombocyto-penia. Inter. J. Gynecol. Obstet., 96 (2): 85 – 88. |
| [14] | McCrae, K. R. (2007). Thrombocytopenia in pregnancy. Platel., 2nd. Ed., pp. 925-942. |
| [15] | Cunningham, F. G., Gant, N. F., Leveno, K. J., Gilstrap, L. C., Hauth, J. C., and Wenstrom, K. D. (2001). Williams obstetrics, 1st ed. McGraw-Hill, Hematological disorders (Chapter 49)., pp. 1307–1338. |
| [16] | Shehata, N., Burrows, R. F., and Kelton, J. G. (1999). Gestational thrombocytopenia. Clin. Obstet. Gynecol, 42: 327- 734. |
| [17] | Wise, R. P., Bonhoeffer, J., Beeler, J., Donato, H., Downie, P., Matthews, D., Pool V., Riise-Bergsaker, M., Tapiainen, T., and Varricchio, F. (2007). Thrombocytopenia: Case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine, 25: 5717–5724 |
| [18] | Parnas, M., Sheiner, E., Burstein, E., Shoham-Vardi, I., Yermiahu, T., Levi, I., Holcberg, G., and Yerushalmi, R. (2006). Moderate to severe thrombocytopenia during pregnancy. Europ. J. Obstet. Gynecol. Reprod. Biol., 128: 163-168. |
| [19] | D’Angelo, A. (2007). 4A. 1 Thrombocytopenia in pregnancy. Thrombosis Res., 119 (1): S37-S38. |
| [20] | Lefkou, E., Hunt, B. J. (2008). Bleeding disorders in pregnancy. Obstet. Gynaecol. Reprod. Med., 18 (8): 217-223. |
| [21] | Burrows, R. F., Kelton, J. G. (1993). Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N. Engl. J. Med., 329: 1463-1466. |
| [22] | Bussel, J., and Cines, D. (2000). Immune thrombocytopenic purpura, neonatal alloimmune thrombocytopenia and post-transfusion purpura. In: Hoffman, R., editor. Hematology basic principles and practice. Philadelphia, Pennsylvania: Churchill Livingstone. pp. 2096-2097. |
| [23] | Montgomery, R. R., and Scott, J. P. (2004). Platelet an blood vessel disorders. In: Behrman, R. E., Kliegman, R. M., and Jenson, H. B., editors. Nelson text book of pediatrics, 17th international edition. Philadelphia: Saunders. pp. 1670–1674. |
| [24] | Mbanya. D., Claude, T. T., Takoeta, E., Mbu, R., and Kaptue, L. (2007). Factors associated with thrombocytopenia among pregnant women in Cameroon. Santé Montrouge France, 17 (4): 213 - 217. |
| [25] | Al-Kouatly, H. B., Chasen, S. T., Kalish, R. B., and Chervenak, F. A. (2003). Causes of thrombocytopenia in triplet gestations. Amer. J. Obstet. Gynecol., 189 (1): 177-180. |
| [26] | Olayemi E., and Akuffo F. W. (2012). Gestational thrombocytopenia among pregnant Ghanaian women. Pan African Med. J., 12: 34. |
| [27] | Verdy, E., and Uzan, S. (1993). Groupe de travail sur les thrombope´nies maternelles et foetales. Plaquettes en cours de grossesse. Etiologie et moyens du diagnostic d’une thrombope´nie maternelle. In: le`re Journe´e parisienne obste´trico-pe´diatrique. Paris: Doin,: 49 - 53. |
| [28] | Shamoon R. P., Muhammed N. S., and Jaff M. S. (2009). Prevalence and etiological classification of thrombocytopenia among a group of pregnant women in Erbil City, Iraq. Turk J. Hematol., 26: 123-128. |
| [29] | Sullivan C. A., Martin J. N. Jr. (1995). Management of the obstetric patient with thrombocytopenia. Clin. Obstet. Gynecol., 38 (3): 521–534. |
| [30] | Akinbami A. A., Ajibola S. O., Rabiu K. A., Adewunmi A. A., Dosunmu A. O., Adediran A., Osunkalu V. O., Osikomaiya B. I., and Ismail K. A. (2013). Hematological profile of normal pregnant women in Lagos, Nigeria. Inter. J. Women Health, 5: 227- 232. |
| [31] | Lee, L. H. (2002). Idiopathic thrombocytopenia in pregnancy. Ann. Acad. Med. Singapore, 3: 335 – 339. |
| [32] | Memon AR, Afsar S. (2006). Thrombocytopenia in hospitalized malaria patients. Pak J Med Sci., 22: 141-143. |
| [33] | Burrows, R. F., and Kelton, J. G. (1990). Thrombocytopenia at delivery. A prospective survey of 6715 deliveries. Am. J. Obstet. Gynecol., 162: 731–734. |
| [34] | Ramsay M. (2010). Normal hematological changes during pregnancy and the puerperium. In: Pavord S, Hunt B (eds) The obstetric hematology manual. Cambridge University Press, Cambridge, pp: 1–11 |
| [35] | McCrae, K. R., Samuels, P., and Schreiber, A. D. (1992). Pregnancy associated thrombocytopenia: Pathogenesis and management. Blood., 80: 2697- 2714. |
APA Style
Samira Muspah Saleh Altayri. (2017). Prevalence of Thrombocytopenia Among Pregnant Women in Tripoli Region, Libya. Cardiology and Cardiovascular Research, 1(1), 23-28. https://doi.org/10.11648/j.ccr.20170101.14
ACS Style
Samira Muspah Saleh Altayri. Prevalence of Thrombocytopenia Among Pregnant Women in Tripoli Region, Libya. Cardiol. Cardiovasc. Res. 2017, 1(1), 23-28. doi: 10.11648/j.ccr.20170101.14
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ccr.20170101.14,
author = {Samira Muspah Saleh Altayri},
title = {Prevalence of Thrombocytopenia Among Pregnant Women in Tripoli Region, Libya},
journal = {Cardiology and Cardiovascular Research},
volume = {1},
number = {1},
pages = {23-28},
doi = {10.11648/j.ccr.20170101.14},
url = {https://doi.org/10.11648/j.ccr.20170101.14},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20170101.14},
abstract = {The aim of this study is to investigate the prevalence and the commonest degree of thrombocytopenia among pregnant women in Tripoli region, Libya. This is cross section study included pregnant women who were admitted to obstetrical ward department of obstetrics and gynecology in Al-gala Hospital, Tripoli, Libya. This study was carried out over a period of 5 month from February 2009 to June 2009 on 3520 pregnant women. 5 ml of venous blood specimens were take from each pregnant woman in K3 EDTA (tubes for the haematological examinations. The analysis of haematological indices was done using automated hematological analyzer. The results showed that 17% of pregnant women were thrombocytopenic. Thrombocytopenia increased with increase of age pregnant women. 81% of patients had mild thrombocytopenia and 19% of patients had moderate thrombocytopenia were found in this study when compared with control group. The incidence of mild thrombocytopenia was 42.5% in age group (30 -39) Followed by 37.8% in age group (20-29). The prevalence of thrombocytopenia increased with increase of the gestational age to reach maximum at the third trimester of gestation. Association of onset of thrombocytopenia disorder with age distribution of patients in age group 20-29 years old were 2.7% during first trimester, 17.8% during second trimester and 79.5% during third trimester. In age group 30 – 39 years old were 3.2% during first trimester, 10.8% during second trimester and 86% during third trimester. In age group 40-49 years old were 46.7% during second trimester and 53.3 during third trimester. 37% of thrombocytopenic pregnant women were anaemic. Association of onset of anaemia disorder with age distribution of patients in age group 20-29 years old were 26.9% during second trimester and 73.1% during third trimester. In age group 30 – 39 years old were 14.3% during second trimester and 85.7% during third trimester. Data shows that 26% of patients had mild anaemia and 8.8% of patients had moderate anaemia and 1.8% severe anaemia cases were found in this study when compared with 62.9% non anaemic. It can be concluded that thrombocytopenia disorders in pregnancy are very common in Tripoli region. Careful surveillance is required for these pregnancies in high-risk units for early detection and treatment of possible complications, in order to try to reduce maternal and neonatal morbidities. Further prospective studies among these high-risk populations with moderate to severe thrombocytopenia should investigate the efficacy of possible surveillance programs.},
year = {2017}
}
TY - JOUR T1 - Prevalence of Thrombocytopenia Among Pregnant Women in Tripoli Region, Libya AU - Samira Muspah Saleh Altayri Y1 - 2017/04/11 PY - 2017 N1 - https://doi.org/10.11648/j.ccr.20170101.14 DO - 10.11648/j.ccr.20170101.14 T2 - Cardiology and Cardiovascular Research JF - Cardiology and Cardiovascular Research JO - Cardiology and Cardiovascular Research SP - 23 EP - 28 PB - Science Publishing Group SN - 2578-8914 UR - https://doi.org/10.11648/j.ccr.20170101.14 AB - The aim of this study is to investigate the prevalence and the commonest degree of thrombocytopenia among pregnant women in Tripoli region, Libya. This is cross section study included pregnant women who were admitted to obstetrical ward department of obstetrics and gynecology in Al-gala Hospital, Tripoli, Libya. This study was carried out over a period of 5 month from February 2009 to June 2009 on 3520 pregnant women. 5 ml of venous blood specimens were take from each pregnant woman in K3 EDTA (tubes for the haematological examinations. The analysis of haematological indices was done using automated hematological analyzer. The results showed that 17% of pregnant women were thrombocytopenic. Thrombocytopenia increased with increase of age pregnant women. 81% of patients had mild thrombocytopenia and 19% of patients had moderate thrombocytopenia were found in this study when compared with control group. The incidence of mild thrombocytopenia was 42.5% in age group (30 -39) Followed by 37.8% in age group (20-29). The prevalence of thrombocytopenia increased with increase of the gestational age to reach maximum at the third trimester of gestation. Association of onset of thrombocytopenia disorder with age distribution of patients in age group 20-29 years old were 2.7% during first trimester, 17.8% during second trimester and 79.5% during third trimester. In age group 30 – 39 years old were 3.2% during first trimester, 10.8% during second trimester and 86% during third trimester. In age group 40-49 years old were 46.7% during second trimester and 53.3 during third trimester. 37% of thrombocytopenic pregnant women were anaemic. Association of onset of anaemia disorder with age distribution of patients in age group 20-29 years old were 26.9% during second trimester and 73.1% during third trimester. In age group 30 – 39 years old were 14.3% during second trimester and 85.7% during third trimester. Data shows that 26% of patients had mild anaemia and 8.8% of patients had moderate anaemia and 1.8% severe anaemia cases were found in this study when compared with 62.9% non anaemic. It can be concluded that thrombocytopenia disorders in pregnancy are very common in Tripoli region. Careful surveillance is required for these pregnancies in high-risk units for early detection and treatment of possible complications, in order to try to reduce maternal and neonatal morbidities. Further prospective studies among these high-risk populations with moderate to severe thrombocytopenia should investigate the efficacy of possible surveillance programs. VL - 1 IS - 1 ER -
Information
Email: